Contributors

Marco Canepa, MD, PhD

Associate Professor of Cardiology, Department of Internal Medicine, University of Genoa (Italy)
Consultant Cardiologist,  IRCCS San Martino Hospital, Genoa (Italy)

Francesco Cappelli, MD, PhD

Tuscan referral center for amyloid treatment
Careggi University Hospital, Florence (Italy)

Alberto Cipriani, MD

Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padua (Italy)
Cardiology Unit, University Hospital of Padua (Italy)

Laura De Michieli, MD

Department of Cardiac, Thoracic and Vascular Sciences and Public Health
University of Padua (Italy)

Simone Longhi, MD, PhD

Cardiology Unit, Cardiac Thoracic and Vascular Department,
IRCCS University Hospital of Bologna (Italy)

Paolo Milani, MD, PhD

Department of Molecular Medicine, University of Pavia.
Amyloidosis Research and Treatment Center, Foundation IRCCS Policlinico San Matteo, Pavia (Italy)

Roberta Mussinelli, MD, PhD

Amyloidosis Research and Treatment Centre
Foundation IRCCS Policlinico San Matteo, Pavia (Italy)

Beatrice Musumeci, MD

Sapienza University, Sant’Andrea Hospital – Rome (Italy)

Laura Obici, MD

Amyloidosis Research and Treatment Centre
Foundation IRCCS Policlinico San Matteo, Pavia (Italy)

Aldostefano Porcari, MD, PhD Student

National Amyloidosis Centre – NHS Royal Free Hospital, UCL, London (United Kingdom).
Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, ASUGI and University of Trieste (Italy)

Giuseppe Vergaro, MD, PhD

Health Science Interdisciplinary Center
Scuola Superiore Sant’Anna, Pisa (Italy)